Simvastatin
Product Images NDC 52959-944

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Simvastatin (NDC 52959-944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H.j. Harkins Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg_30tabs (16729 004 50)

Simvastatin 20mg tablet packaging label from H.J. Harkins Company, Inc. The label includes lot number SVT02X1, expiration date 03/12, and manufacturer ACCORD India. It compares the product to Zocor with Mfg. NDC 16729-005-17. The label identifies the tablet as brick-red and includes usage directions advising to follow doctor's instructions. Four identical small labels display quantity of 30 tablets each.*

FDA Label Image

40mg_30tabs (16729 004 90)

Packaging label for Simvastatin 40 mg tablet from H.J. Harkins Company, Inc. The label includes the lot number SMS40X1, manufacture date and expiration date 09/11, and identifies the product as brick-red tablets. It references a comparison to Zocor with NDC 16729-006-10 and contains dosage instructions to take as directed by a doctor or to see the outer packaging for dosage information.*

FDA Label Image

Simvastatin (Simvastatin 1)

Chemical structure of simvastatin showing its molecular configuration with labeled carbon, hydrogen, and oxygen atoms in a detailed diagram.*

FDA Label Image

Simvastatin (Simvastatin 2)

A risk ratio forest plot depicting the incidence of major vascular and major coronary events among subgroups of patients taking Simvastatin tablets versus placebo. Subgroups are categorized by baseline characteristics including presence of cardiovascular diseases, diabetes status, gender, age, and cholesterol levels, with confidence intervals shown for each. The plot visually compares relative risk and favors between Simvastatin and placebo groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.